Philip Q Ding

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Squamous Cell Carcinoma

Smoking Cessation

Small Cell Lung Cancer

Clinical Practice

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Cha Len Lee, Mark Freeman, Kelly W Burak, Gordon T Moffat, Conor D J O'Donnell, Philip Q Ding, Hanna Lyubetska, Brandon M Meyers, Vallerie Gordon, Ekaterina Kosyachkova, Roxana Bucur, Winson Y Cheung, Jennifer J Knox, Vincent C Tam
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications. Cancers 16 (16) (2024)
Cha Len Lee, Mark Freeman, Kelly W Burak, Gordon T Moffat, Conor D J O'Donnell, Philip Q Ding, Hanna Lyubetska, Brandon M Meyers, Vallerie Gordon, Ekaterina Kosyachkova, Roxana Bucur, Winson Y Cheung, Jennifer J Knox, Vincent C Tam
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications. Cancers 16 (16) (2024)
John Paul Yun, Philip Q Ding, Aastha Dolley, Winson Y Cheung
Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada. Current oncology (Toronto, Ont.) 30 (9) (2023)
Philip Q Ding, Flora Au, Winson Y Cheung, Steven J Heitman, Richard Lee-Ying
Cost-Effectiveness of Surveillance after Metastasectomy of Stage IV Colorectal Cancer. Cancers 15 (16) (2023)
Taylor E Woo, Igor Stukalin, Philip Q Ding, Siddhartha Goutam, Michael S Sander, Benjamin W Ewanchuk, Winson Y Cheung, Daniel Y C Heng, Tina Cheng
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current oncology (Toronto, Ont.) 30 (10) (2023)
Philip Q Ding, Brandt J Newcomer, Winson Y Cheung
Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada. Cancers 14 (24) (2022)
Philip Q Ding, Aastha Dolley, Winson Y Cheung
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. Current oncology (Toronto, Ont.) 30 (1) (2022)
Philip Q Ding, Aastha Dolley, Winson Y Cheung
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. Current oncology (Toronto, Ont.) 30 (1) (2022)
Philip Q Ding, Aastha Dolley, Winson Y Cheung
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. Current oncology (Toronto, Ont.) 30 (1) (2022)
Philip Q Ding, Aastha Dolley, Winson Y Cheung
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. Current oncology (Toronto, Ont.) 30 (1) (2022)
Philip Q Ding, Aastha Dolley, Winson Y Cheung
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. Current oncology (Toronto, Ont.) 30 (1) (2022)
Philip Q Ding, Brandt J Newcomer, Winson Y Cheung
Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada. Cancers 14 (24) (2022)
Philip Q Ding, Aastha Dolley, Winson Y Cheung
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada. Current oncology (Toronto, Ont.) 30 (1) (2022)
Rodrigo Rigo, Jordan Doherty, Kim Koczka, Shiying Kong, Philip Q Ding, Tina Cheng, Winson Y Cheung, Jose G Monzon
Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis. Current oncology (Toronto, Ont.) 28 (5) (2021)
Heidi A I Grosjean, Samantha Dolter, Daniel E Meyers, Philip Q Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y C Heng, D Gwyn Bebb, Don G Morris, Winson Y Cheung, Aliyah Pabani
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database. Current oncology (Toronto, Ont.) 28 (5) (2021)